Feb 9, 2026 05:55AM

Oct 31, 2025 04:55AM

Nov 15, 2024 07:18AM

Sep 25, 2024 06:50AM

Jul 29, 2024 06:56AM

May 4, 2023 08:50AM

Nov 14, 2022 04:31AM Roche's Alzheimer's drug fails to meet goal in long awaited trial

Sep 28, 2022 03:41PM

Sep 28, 2022 06:54AM

Sep 28, 2022 05:26AM

Sep 28, 2022 05:13AM

Dec 20, 2021 02:38PM

Oct 19, 2021 01:55PM

Sep 24, 2021 06:51AM Biogen (BIIB) PT Lowered to $296 at Baird as Aduhelm Numbers Seen Weak on Safety Issues

Jun 7, 2021 04:47PM

Nov 9, 2020 08:06AM

Jun 18, 2020 12:14PM

Feb 5, 2020 03:04PM

Jan 23, 2020 10:55AM

Dec 2, 2019 06:51AM

Dec 2, 2019 05:07AM Baird Downgrades Biogen (BIIB) to Underperform on Alzheimer's Hype, 'CTAP Looks Ripe for Downside'

Oct 22, 2019 05:08PM

Mar 21, 2019 08:20AM

Jan 3, 2019 07:06AM

Oct 25, 2018 01:25PM

Jul 25, 2018 06:40AM

Jul 10, 2018 06:40AM

Apr 25, 2018 04:37AM UPDATE: Baird Upgrades Biogen (BIIB) to Outperform

Aug 31, 2017 07:41AM

Apr 25, 2017 09:29AM

Apr 13, 2017 10:25AM

Mar 29, 2017 06:58AM

Mar 7, 2017 06:30AM

Feb 7, 2017 05:57AM

Jan 20, 2017 06:42AM Biogen (BIIB): Tecfidera Sales Could Be Weak - Baird

Jan 17, 2017 11:29AM

Dec 20, 2016 12:21PM

Dec 9, 2016 06:34AM

Nov 23, 2016 10:40AM

Nov 7, 2016 10:38AM

Aug 3, 2016 07:17AM

Aug 1, 2016 03:16PM Baird Incrementally Positive on Biogen (BIIB) Nusinersen Data; PT to $284

Jun 29, 2016 12:39PM

Jun 22, 2016 03:53PM

Jun 22, 2016 03:33PM

Jun 22, 2016 07:56AM

Mar 11, 2016 07:20AM

Sep 1, 2015 10:40AM

Jul 27, 2015 06:35AM Baird Downgrades Biogen (BIIB) to Neutral; Diminished Growth Prospects

Jul 24, 2015 09:29AM

28,059 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All